Literature DB >> 22074423

Antimycobacterial evaluation of pyrazinoic acid reversible derivatives.

Martin Dolezal1, Diana Kesetovic, Jan Zitko.   

Abstract

Design, results of in vitro antimycobacterial evaluation, and study of structure-activity relationships of various pyrazinecarboxylic acid reversible derivatives are presented. This review deals with some pyrazinamide analogues/prodrugs derived from Nphenylpyrazine- 2-carboxamides (1), arylaminopyrazine-2,5-dicarbonitriles (2), aryl/alkylsulphanylpyrazines (3,4), and aroylpyrazines (5) effecting >50% inhibition in the primary antimycobacterial screen. The promising pyrazine candidates for further antimycobacterial evaluation were discovered. Results give good view onto structure-activity relationships of these analogues and promise even better activity of new compounds prepared after some structure optimization experiments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074423     DOI: 10.2174/138161211798194477

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  5 in total

1.  Synthesis, antimycobacterial activity and in vitro cytotoxicity of 5-chloro-N-phenylpyrazine-2-carboxamides.

Authors:  Jan Zitko; Barbora Servusová; Pavla Paterová; Jana Mandíková; Vladimír Kubíček; Radim Kučera; Veronika Hrabcová; Jiří Kuneš; Ondřej Soukup; Martin Doležal
Journal:  Molecules       Date:  2013-12-02       Impact factor: 4.411

2.  Design, Synthesis and Evaluation of N-pyrazinylbenzamides as Potential Antimycobacterial Agents.

Authors:  Jan Zitko; Alžběta Mindlová; Ondřej Valášek; Ondřej Jand'ourek; Pavla Paterová; Jiří Janoušek; Klára Konečná; Martin Doležal
Journal:  Molecules       Date:  2018-09-18       Impact factor: 4.411

3.  Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with a 4-phenylthiazol-2-amine scaffold.

Authors:  Jan Zitko; Ondřej Jand'ourek; Pavla Paterová; Lucie Navrátilová; Jiří Kuneš; Jarmila Vinšová; Martin Doležal
Journal:  Medchemcomm       Date:  2018-02-22       Impact factor: 3.597

4.  Substituted N-benzylpyrazine-2-carboxamides: synthesis and biological evaluation.

Authors:  Barbora Servusová; Drahomíra Eibinová; Martin Doležal; Vladimír Kubíček; Pavla Paterová; Matúš Peško; Katarína Kráľová
Journal:  Molecules       Date:  2012-11-06       Impact factor: 4.411

5.  5-Alkylamino-N-phenylpyrazine-2-carboxamides: Design, Preparation, and Antimycobacterial Evaluation.

Authors:  Weronika Ambrożkiewicz; Marta Kučerová-Chlupáčová; Ondřej Janďourek; Klára Konečná; Pavla Paterová; Pavel Bárta; Jarmila Vinšová; Martin Doležal; Jan Zitko
Journal:  Molecules       Date:  2020-03-28       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.